All Stories

  1. Risk Stratification in Pulmonary Hypertension in the UAE
  2. Diagnosis and Management of Group 3 Pulmonary Hypertension in the UAE: Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD)
  3. Group 5 PH: Diagnosis and Management of Pulmonary Hypertension in Patients with a Focus on Chronic Haemolytic Diseases in the UAE
  4. Diagnosis and Management of PAH in Special Populations in the UAE
  5. Diagnosis and Management of Group 2 Pulmonary Hypertension Due to Left Heart Disease in the UAE
  6. Diagnosis and Management of Group 1 Pulmonary Arterial Hypertension in the UAE
  7. Diagnosis and Management of the Connective Tissue Disease-associated PAH in the UAE
  8. Diagnosis and Management of Group 4 PH (Chronic Thromboembolic Pulmonary Hypertension (CTEPH)) in the UAE
  9. Introduction, Clinical Classification, and Genetics of Pulmonary Hypertension in the UAE
  10. Diagnosis of Pulmonary Hypertension
  11. Experts' Perspectives on the Current Practices and Gaps in the Management of Dyslipidemia: A Report from The United Arab Emirates
  12. Prevalence of Cardiovascular Risk Factors and 10-Years Risk for Coronary Heart Disease in the United Arab Emirates
  13. Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations
  14. Patient adherence to Novel Oral Anticoagulants (NOACs) for the treatment of Atrial Fibrillation and occurrence of associated bleeding events: A Systematic Review and Meta-analysis